Stollmann Implements Bluetooth for Continua Health Alliance

Stollmann Entwicklungs- und Vertriebs-GmbHStollmann has been one of the first manufacturers in the world to implement the Bluetooth SIG's Health Device Profile (HDP) for medical devices. According to the terms of their cooperative agreement, Stollmann is now making this profile available to the members of the Continua Health Alliance, an organization of the most important global medical device manufacturers. Continua had chosen Stollmann, together with another partner, as technology leader for this project. The Bluetooth HDP was selected by the Continua Health Alliance for the wireless transmission of standard data records pursuant to the IEEE 11073 standard.

Stollmann is the only German manufacturer to participate in the international standardization efforts for the Bluetooth HDP for medical devices. The Bluetooth HDP facilitates the concurrent transmission of multiple data streams, safe wireless data transfer, and the synchronization of medical sensors, thus paving the way for the transmission of patient data for use in remote and local patient monitoring.

While Bluetooth has been integrated in medical devices before, interoperability of devices made by different manufacturers has not been assured to date. The Bluetooth Health Device Profile now fills this gap by providing a standard format for medical data interchange.

Stollmann joined the Continua Health Alliance in May this year. The Alliance has more than 150 members working on application guidelines and interoperability standards for medical devices.

About Stollmann Entwicklungs- und Vertriebs-GmbH
Stollmann, based in Hamburg, Germany, is one of the leading developers and suppliers of standard products and licensed products for communications technologies such as ISDN, Bluetooth, NFC, GPRS, and xDSL. Stollmanns team of 44 specialists develops modules, protocol stacks, and reference designs. For more information, please visit www.stollmann.de.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...